IDIS

Idis supplies patients with medicines that are not routinely available in their own countries. The Surrey company sources 20,000 medicines for healthcare providers and pharmaceutical and biotechnology companies. With offices in America, France and India, international sales now account for 75% of revenue. Backed by CBPE Capital, the company is led by managing director, Tony Dutta, 50.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
Year2013
Rank225
CompanyIDIS
ActivityPharmaceuticals supplier
LocationWeybridge
Sales £m145.6
Operating profit £m11.6
Main shareholdersCBPE Capital (65%), Natalie Douglas (30%), other (5%)
Staff180
Founded1987
Websitewww.idispharma.com

If applicable:

* supplied by Company   † annualised figure   ‡  profit = ebitda